Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions

被引:41
作者
Shukla, Suneet [1 ]
Abel, Biebele [1 ]
Chufan, Eduardo E. [1 ]
Ambudkar, Suresh V. [1 ]
机构
[1] NCI, Lab Cell Biol, Ctr Canc Res, NIH, 37 Convent Dr,Rm 2120, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
BINDING CASSETTE TRANSPORTER; MULTIDRUG TRANSPORTER; ATP-BINDING; ELECTRON-MICROSCOPY; CATALYTIC CYCLE; DRUG-BINDING; RESISTANCE; ABCB1; INHIBITION; MECHANISM;
D O I
10.1074/jbc.M116.771634
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolysis to export many structurally dissimilar hydrophobic and amphipathic compounds, including anticancer drugs from cells. Several structural studies on purified P-gp have been reported, but only limited and sometimes conflicting information is available on ligand interactions with the isolated transporter in a dodecyl-maltoside detergent environment. In this report we compared the biochemical properties of P-gp in native membranes, detergent micelles, and when reconstituted in artificial membranes. We found that the modulators zosuquidar, tariquidar, and elacridar stimulated the ATPase activity of purified human or mouse P-gp in a detergent micelle environment. In contrast, these drugs inhibited ATPase activity in native membranes or in proteoliposomes, with IC50 values in the 10-40 nM range. Similarly, a 30-150-fold decrease in the apparent affinity for verapamil and cyclic peptide inhibitor QZ59-SSS was observed in detergent micelles compared with native or artificial membranes. Together, these findings demonstrate that the high-affinity site is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment. The ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity. We, therefore, recommend studying structural and functional aspects of ligand interactions with purified P-gp and other ATP-binding cassette transporters that transport amphipathic or hydrophobic substrates in a detergent-free native or artificial membrane environment.
引用
收藏
页码:7066 / 7076
页数:11
相关论文
共 50 条
  • [21] Structure-Function Relationships in the Human P-Glycoprotein (ABCB1): Insights from Molecular Dynamics Simulations
    Mora Lagares, Liadys
    Perez-Castillo, Yunierkis
    Minovski, Nikola
    Novic, Marjana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [22] Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency
    Vahedi, Shahrooz
    Chufan, Eduardo E.
    Ambudkar, Suresh V.
    BIOCHEMICAL PHARMACOLOGY, 2017, 143 : 53 - 64
  • [23] FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitinproteasome pathway in cancer cells
    Katayama, Kazuhiro
    Noguchi, Kohji
    Sugimoto, Yoshikazu
    CANCER SCIENCE, 2013, 104 (06) : 694 - 702
  • [24] Establishment and characterization of an MDCK cell line stably-transfected with chicken Abcb1 encoding P-glycoprotein
    Sun, Yong
    Guo, Tingting
    Guo, Dawei
    Guo, Li
    Chen, Li
    Zhang, Yu
    Wang, Liping
    RESEARCH IN VETERINARY SCIENCE, 2016, 106 : 37 - 44
  • [25] Modeling drug-drug interactions of AZD1208 with Vincristine and Daunorubicin on ligand-extrusion binding TMD-domains of multidrug resistance P-glycoprotein (ABCB1)
    Marques, Maiara Bernardes
    de Oliveira, Patricia Viera
    Fagan, Solange Binotto
    Oliveira, Bruno Rodrigues
    da Silva Nornberg, Bruna Felix
    Almeida, Daniela Volcan
    Marins, Luis Fernando
    Gonzalez-Durruthy, Michael
    TOXICOLOGY, 2019, 411 : 81 - 92
  • [26] Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)
    Abel, Biebele
    Tosh, Dilip K.
    Durell, Stewart R.
    Murakami, Megumi
    Vahedi, Shahrooz
    Jacobson, Kenneth A.
    Ambudkar, Suresh, V
    MOLECULAR PHARMACOLOGY, 2019, 96 (02) : 180 - 192
  • [27] Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1)
    Sajid, Andaleeb
    Raju, Natarajan
    Lusvarghi, Sabrina
    Vahedi, Shahrooz
    Swenson, Rolf E.
    Ambudkar, Suresh, V
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1013 - 1023
  • [28] Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells
    Abraham, Ioana
    Jain, Sandeep
    Wu, Chung-Pu
    Khanfar, Mohammad A.
    Kuang, Yehong
    Dai, Chun-Ling
    Shi, Zhi
    Chen, Xiang
    Fu, Liwu
    Ambudkar, Suresh V.
    El Sayed, Khalid
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (10) : 1497 - 1506
  • [29] Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice
    Loos, Nancy H. C.
    Martins, Margarida L. F.
    de Jong, Danielle
    Lebre, Maria C.
    Tibben, Matthijs
    Beijnen, Jos H.
    Schinkel, Alfred H.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 650
  • [30] Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1)
    Orchard, Alexandra
    Schamerhorn, Gregory A.
    Calitree, Brandon D.
    Sawada, Geri A.
    Loo, Tip W.
    Bartlett, M. Claire
    Clarke, David M.
    Detty, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (14) : 4290 - 4302